“It's not that there are any problems with financing now, but if the LBO market continues to grow or the number of large deals increases, we don’t think the current lending structure will be viable,” ...

A notable such example is the US$282m five-year LBO financing for Harbin Pharmaceutical Group Holding that was cancelled in March 2006 after having been in the market for more than three months.